Showing results (181-190 of 214) with videos related to
Sort By:
Pageof 22
Journal of Surgical Oncology|May 1, 1994
Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: how effective is this diagnostic triad?M Haid, D Rabin, K M King, et al.Journal of Ophthalmology|April 14, 2020
Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in ItalyM La Cava, A Bruscolini, M Sacchetti, et al.The European Respiratory Journal|June 27, 2008
The relation between paracetamol use and asthma: a GA2LEN European case-control studyS Shaheen, J Potts, L Gnatiuc, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 22, 2010
Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapiesS Mammoliti, V Andretta, E Bennicelli, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 15, 2011
Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overviewP Cocchi, L Cariani, F Favari, et al.Clinical and Experimental Obstetrics & Gynecology|November 17, 2010
Perineal ultrasound evaluation of urethral mobility after the TVT-O procedureL Di Pietto, C Scaffa, A Lambiase, et al.Allergy|September 24, 2009
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in EuropeG J Burbach, L M Heinzerling, G Edenharter, et al.Allergy|October 15, 2009
GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patientsP-J Bousquet, G Burbach, L M Heinzerling, et al.British Journal of Cancer|July 2, 2009
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumoursV Gregorc, A Santoro, E Bennicelli, et al.British Journal of Cancer|May 31, 2012
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patientsD Lorusso, G Scambia, G Amadio, et al.Pageof 22